Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 19, 2026.

Food Insecurity as a Barrier to Sustained Antiretroviral Therapy Adherence in Uganda

Sheri D. Weiser, David M. Tuller, Edward A. Frongillo and 3 more (opens in a new tab)

PLoS ONE · 2010

doi:10.1371/journal.pone.0010340 (opens in a new tab)

Abstract

Background. Food insecurity is emerging as an important barrier to antiretroviral (ARV) adherence in sub-Saharan Africa and elsewhere, but little is known about the mechanisms through which food insecurity leads to ARV non-adherence and treatment interruptions.

Methodology. We conducted in-depth, open-ended interviews with 47 individuals (30 women, 17 men) living with HIV/AIDS recruited from AIDS treatment programs in Mbarara and Kampala, Uganda to understand how food insecurity interferes with ARV therapy regimens. Interviews were transcribed, coded for key themes, and analyzed using grounded theory.

Findings. Food insecurity was common and an important barrier to accessing medical care and ARV adherence. Five mechanisms emerged for how food insecurity can contribute to ARV non-adherence and treatment interruptions or to postponing ARV initiation: 1) ARVs increased appetite and led to intolerable hunger in the absence of food; 2) Side effects of ARVs were exacerbated in the absence of food; 3) Participants believed they should skip doses or not start on ARVs at all if they could not afford the added nutritional burden; 4) Competing demands between costs of food and medical expenses led people either to default from treatment, or to give up food and wages to get medications; 5) While working for food for long days in the fields, participants sometimes forgot medication doses. Despite these obstacles, many participants still reported high ARV adherence and exceptional motivation to continue therapy.

Conclusions. While reports from sub-Saharan Africa show excellent adherence to ARVs, concerns remain that these successes are not sustainable in the presence of widespread poverty and food insecurity. We provide further evidence on how food insecurity can compromise sustained ARV therapy in a resource-limited setting. Addressing food insecurity as part of emerging ARV treatment programs is critical for their long-term success.

References 44

  1. 1.

    Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. Aids. 2000;14:357-366.

    Not in our library10.1097/00002030-200003100-00008 (opens in a new tab)

  2. 2.

    Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. Aids. 2001;15:1181-1183.

    Not in our library10.1097/00002030-200106150-00015 (opens in a new tab)

  3. 3.

    Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, et al. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350×10(9) cells/L. Ann Intern Med. 2003;139:810-816.

    Not in our library10.7326/0003-4819-139-10-200311180-00008 (opens in a new tab)

  4. 4.

    Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.

    Not in our library10.7326/0003-4819-133-1-200007040-00004 (opens in a new tab)

  5. 5.

    Garcia de Olalla P, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, et al. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;30:105-110.

    Not in our library10.1097/00042560-200205010-00014 (opens in a new tab)

  6. 6.

    Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33:1417-1423.

    Not in our library10.1086/323201 (opens in a new tab)

  7. 7.

    Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34:281-288.

    Not in our library10.1097/00126334-200311010-00004 (opens in a new tab)

  8. 8.

    Crane JT, Kawuma A, Oyugi JH, Byakika JT, Moss A, et al. The price of adherence: qualitative findings from HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda. AIDS Behav. 2006;10:437-442.

    Not in our library10.1007/s10461-006-9080-z (opens in a new tab)

  9. 9.

    Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, et al. Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int J STD AIDS. 2005;16:38-41.

    Not in our library10.1258/0956462052932548 (opens in a new tab)

  10. 10.

    Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis. 2005;41:217-224.

    Not in our library10.1086/431199 (opens in a new tab)

  11. 11.

    Kumarasamy N, Safren SA, Raminani SR, Pickard R, James R, et al. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. AIDS Patient Care STDS. 2005;19:526-537.

    Not in our library10.1089/apc.2005.19.526 (opens in a new tab)

  12. 12.

    Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. Jama. 2006;296:679-690.

    Not in our library10.1001/jama.296.6.679 (opens in a new tab)

  13. 13.

    Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19:658-665.

    Not in our library10.1080/09540120701244943 (opens in a new tab)

  14. 14.
  15. 15.

    Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, et al. Transportation Costs Impede Sustained Adherence and Access to HAART in a Clinic Population in Southwestern Uganda: A Qualitative Study. AIDS Behav. 2009.

    Not in our library10.1007/s10461-009-9533-2 (opens in a new tab)

  16. 16.

    Normen L, Chan K, Braitstein P, Anema A, Bondy G, et al. Food insecurity and hunger are prevalent among HIV-positive individuals in British Columbia, Canada. J Nutr. 2005;135:820-825.

    Not in our library10.1093/jn/135.4.820 (opens in a new tab)

  17. 17.

    Au JT, Kayitenkore K, Shutes E, Karita E, Peters PJ, et al. Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda. Aids. 2006;20:2116-2118.

    Not in our library10.1097/01.aids.0000247580.16073.1b (opens in a new tab)

  18. 18.

    Sanjobo N, Frich JC, Fretheim A. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study. Sahara J. 2008;5:136-143.

    Not in our library10.1080/17290376.2008.9724912 (opens in a new tab)

  19. 19.

    Olupot-Olupot P, Katawera A, Cooper C, Small W, Anema A, et al. Adherence to antiretroviral therapy among a conflict-affected population in Northeastern Uganda: a qualitative study. Aids. 2008;22:1882-1884.

    Not in our library10.1097/qad.0b013e3283112ba6 (opens in a new tab)

  20. 20.

    Nachega JB, Knowlton AR, Deluca A, Schoeman JH, Watkinson L, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S127-133.

    Not in our library10.1097/01.qai.0000248349.25630.3d (opens in a new tab)

  21. 21.

    Olupot-Olupot P, Katawera A, Cooper C, Small W, Anema A, et al. Adherence to antiretroviral therapy among a conflict-affected population in Northeastern Uganda: a qualitative study. AIDS. 2008;22:1882-1884.

    Not in our library10.1097/qad.0b013e3283112ba6 (opens in a new tab)

  22. 22.

    2003.

    Not in our library

  23. 23.

    Bukusuba J, Kikafunda JK, Whitehead RG. Food security status in households of people living with HIV/AIDS (PLWHA) in a Ugandan urban setting. Br J Nutr. 2007;98:211-217.

    Not in our library10.1017/s0007114507691806 (opens in a new tab)

  24. 24.

    Seume-Fosso E, Rajabiun S, Cogill B, Elder L, Castleman T, et al. Food and Nutrition Technical Assistance. 2004.

    Not in our library

  25. 25.

    Nutrition and HIV/AIDS. Statement by the Administrative Committee on Coordination, Sub-Committee on Nutrition at its 28th Session. 2001.

    Not in our library

  26. 26.

    Programming in the Era of AIDS: WPF's Response to HIV/AIDS. 2003.

    Not in our library

  27. 27.

    World Health Organization. 2003.

    Not in our library

  28. 28.

    United Nations General Assembly.

    Not in our library

  29. 29.

    Strauss A, Corbin J. Basics of Qualitative Research: Grounded Theory Procedures and Techniques. 1990.

    Not in our library

  30. 30.

    Mshana GH, Wamoyi J, Busza J, Zaba B, Changalucha J, et al. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS. 2006;20:649-657.

    Not in our library10.1089/apc.2006.20.649 (opens in a new tab)

  31. 31.

    Ramadhani HO, Thielman NM, Landman KZ, Ndosi EM, Gao F, et al. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis. 2007;45:1492-1498.

    Not in our library10.1086/522991 (opens in a new tab)

  32. 32.
  33. 33.

    Hadley C, Lindstrom D, Tessema F, Belachew T. Gender bias in the food insecurity experience of Ethiopian adolescents. Soc Sci Med. 2008;66:427-438.

    Not in our library10.1016/j.socscimed.2007.08.025 (opens in a new tab)

  34. 34.

    Laurent C, Ngom Gueye NF, Ndour CT, Gueye PM, Diouf M, et al. Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. J Acquir Immune Defic Syndr. 2005;38:14-17.

    Not in our library10.1097/00126334-200501010-00003 (opens in a new tab)

  35. 35.

    Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. Aids. 2007;21:965-971.

    Not in our library10.1097/qad.0b013e32802e6bfa (opens in a new tab)

  36. 36.

    Danel C, Moh R, Chaix ML, Gabillard D, Gnokoro J, et al. Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults. J Infect Dis. 2009;199:66-76.

    Not in our library10.1086/595298 (opens in a new tab)

  37. 37.

    Hogg RS, Heath K, Bangsberg D, Yip B, Press N, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. Aids. 2002;16:1051-1058.

    Not in our library10.1097/00002030-200205030-00012 (opens in a new tab)

  38. 38.

    Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360:1815-1826.

    Not in our library10.1056/nejmoa0807252 (opens in a new tab)

  39. 39.

    van Sighem AI, van de Wiel MA, Ghani AC, Jambroes M, Reiss P, et al. Mortality and progression to AIDS after starting highly active antiretroviral therapy. Aids. 2003;17:2227-2236.

    Not in our library10.1097/00002030-200310170-00011 (opens in a new tab)

  40. 40.

    Weiser SD, Fernandes KA, Brandson EK, Lima VD, Anema A, et al. The association between food insecurity and mortality among HIV-infected individuals on HAART. Journal of AIDS, In Press. 2009.

    Not in our library10.1097/qai.0b013e3181b627c2 (opens in a new tab)

All 44 references

Cited by papers we hold 3

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.